Patents by Inventor Colin M. McKee

Colin M. McKee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF SYNTHESISING ADCS USING AFFINITY RESINS
    Publication number: 20190216819
    Abstract: This invention relates to a solid phase method of synthesising biomolecule-drug-conjugates. In particular, this invention relates to a solid phase method of synthesising antibody-drug-conjugates (ADCs). This invention also relates to intermediate methods of producing immobilised, chemically modified biomolecules, e.g. antibodies. The invention also relates to various uses of capture resins and to biomolecule-drug-conjugates, intermediate products and compositions of the methods of the invention.
    Type: Application
    Filed: January 31, 2019
    Publication date: July 18, 2019
    Inventors: David J. Evans, Colin M. McKee
  • Method of synthesising ADCs using affinity resins
    Patent number: 10201544
    Abstract: This invention relates to a solid phase method of synthesizing biomolecule-drug conjugates. In particular, this invention relates to a solid phase method of synthesizing antibody-drug conjugates (ADCs). This invention also relates to intermediate methods of producing immobilized, chemically modified biomolecules, e.g. antibodies. The invention also relates to various uses of capture resins and to biomolecule-drug conjugates, intermediate products and compositions prepared by the methods of the invention.
    Type: Grant
    Filed: April 25, 2014
    Date of Patent: February 12, 2019
    Assignee: ADC Biotechnology Ltd.
    Inventors: David J. Evans, Colin M. McKee
  • Method of Synthesising ADCs Using Affinity Resins
    Publication number: 20160067352
    Abstract: This invention relates to a solid phase method of synthesizing biomolecule-drug conjugates. In particular, this invention relates to a solid phase method of synthesizing antibody-drug conjugates (ADCs). This invention also relates to intermediate methods of producing immobilized, chemically modified biomolecules, e.g. antibodies. The invention also relates to various uses of capture resins and to biomolecule-drug conjugates, intermediate products and compositions prepared by the methods of the invention.
    Type: Application
    Filed: April 25, 2014
    Publication date: March 10, 2016
    Inventors: David J. Evans, Colin M. McKee